We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Variability in How Cancer Cells Respond to Drugs Investigated

News   Oct 30, 2017 | Original story by Kevin Jiang for Harvard Medical School

 
Variability in How Cancer Cells Respond to Drugs Investigated
 
 
 

RELATED ARTICLES

Mouse Study Proposals Promising Parkinson's Molecule

News

A promising molecule has offered hope for a new treatment that could stop or slow Parkinson's. Researchers have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson's, as well as protect the dopamine-producing brain cells from dying.

READ MORE

Study Links Thyroid Cancer, Genetic Variations and Cell Phones

News

Radiation from cell phones is linked to higher rates of thyroid cancer among people with genetic variations in specific genes, a new study led by the Yale School of Public Health finds.

READ MORE

Novel Drug Targets Advanced Kidney Cancer

News

Scientists have reported promising activity of a novel drug called MK-6482, that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease. The study authors concluded that the drug was well-tolerated with a favorable safety profile.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE